HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- one

a Dusp6 inhibitor; structure in first source
Also Known As:
(2E)-2-Benzylidene-3-(cyclohexylamino)-1-indanone; (E)-2-benzylidene-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one; BCI
Networked: 1103 relevant articles (88 outcomes, 235 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Guan, Cuntai: 30 articles (01/2021 - 02/2007)
2. Ang, Kai Keng: 24 articles (01/2021 - 01/2008)
3. Birbaumer, Niels: 23 articles (11/2021 - 01/2007)
4. Phua, Kok Soon: 20 articles (01/2021 - 01/2008)
5. Prabhakaran, Vivek: 16 articles (01/2021 - 01/2014)
6. Nair, Veena A: 15 articles (01/2021 - 01/2014)
7. Kübler, Andrea: 15 articles (01/2020 - 01/2010)
8. Williams, Justin C: 14 articles (01/2021 - 06/2006)
9. Ushiba, Junichi: 13 articles (01/2022 - 09/2010)
10. Young, Brittany M: 13 articles (01/2021 - 01/2014)

Related Diseases

1. Stroke (Strokes)
2. Fatigue
3. Wounds and Injuries (Trauma)
4. Mixed Conductive-Sensorineural Hearing Loss
5. Deafness (Deaf Mutism)

Related Drugs and Biologics

1. Silver Sulfadiazine (SSD)
2. 2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- one
3. Solutions
4. Hydrogels
5. Tamsulosin (Flomax)
6. salicylhydroxamic acid (SHAM)
7. Tamoxifen
8. Biomarkers (Surrogate Marker)
9. Therapeutic Uses
10. Estrogen Receptors

Related Therapies and Procedures

1. Brain-Computer Interfaces
2. Therapeutics
3. Neurofeedback
4. Transcranial Direct Current Stimulation
5. Neurological Rehabilitation